DK1987063T3 - Peptider og peptidderivater, fremstilling deraf samt deres anvendelse til fremstilling af en terapeutisk og/eller præventivt aktiv farmaceutisk sammensætning - Google Patents
Peptider og peptidderivater, fremstilling deraf samt deres anvendelse til fremstilling af en terapeutisk og/eller præventivt aktiv farmaceutisk sammensætningInfo
- Publication number
- DK1987063T3 DK1987063T3 DK07701339T DK07701339T DK1987063T3 DK 1987063 T3 DK1987063 T3 DK 1987063T3 DK 07701339 T DK07701339 T DK 07701339T DK 07701339 T DK07701339 T DK 07701339T DK 1987063 T3 DK1987063 T3 DK 1987063T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- peptides
- preventatively
- therapeutically
- pharmaceutical composition
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940124599 anti-inflammatory drug Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT3022006 | 2006-02-23 | ||
| PCT/AT2007/000096 WO2007095661A1 (en) | 2006-02-23 | 2007-02-23 | Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1987063T3 true DK1987063T3 (da) | 2010-01-04 |
Family
ID=38037441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07701339T DK1987063T3 (da) | 2006-02-23 | 2007-02-23 | Peptider og peptidderivater, fremstilling deraf samt deres anvendelse til fremstilling af en terapeutisk og/eller præventivt aktiv farmaceutisk sammensætning |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US8067533B2 (enExample) |
| EP (1) | EP1987063B1 (enExample) |
| JP (1) | JP2009527503A (enExample) |
| AT (1) | ATE443722T1 (enExample) |
| AU (1) | AU2007219032B2 (enExample) |
| CA (1) | CA2641909A1 (enExample) |
| CY (1) | CY1109537T1 (enExample) |
| DE (1) | DE602007002553D1 (enExample) |
| DK (1) | DK1987063T3 (enExample) |
| ES (1) | ES2333374T3 (enExample) |
| PL (1) | PL1987063T3 (enExample) |
| PT (1) | PT1987063E (enExample) |
| SI (1) | SI1987063T1 (enExample) |
| WO (1) | WO2007095661A1 (enExample) |
| ZA (1) | ZA200807027B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20060366A1 (it) * | 2006-03-01 | 2007-09-02 | C4T S C A R L | Composti organo tiopirosfosfati metodo per prepararli e composizioni che li contengono |
| WO2009038729A2 (en) * | 2007-09-17 | 2009-03-26 | Regenerx Biopharmaceuticals, Inc. | Compositions and methods utilizing fibrin beta chain fragments of the bbeta chain of fibrinogen |
| WO2010043444A2 (en) * | 2008-10-15 | 2010-04-22 | Fibrex Medical Research & Development Gmbh | Pharmaceutical preparation for the treatment and/or prevention of ischemia/reperfusion injury and the sequels thereof |
| US20100152832A1 (en) * | 2008-12-12 | 2010-06-17 | Medtronic Vascular, Inc. | Apparatus and Methods for Treatment of Aneurysms With Fibrin Derived Peptide B-Beta |
| PL2464655T3 (pl) * | 2009-08-11 | 2017-08-31 | Biocon Limited | Procesy chromatograficzne |
| WO2011060018A2 (en) * | 2009-11-13 | 2011-05-19 | Ikaria Development Subsidiary Two Llc | Compositions and methods for using peptides, modified peptides, peptidomimetics and fibrin derivatives |
| US20120084736A1 (en) * | 2010-10-01 | 2012-04-05 | Flextronics Id, Llc | Gesture controlled screen repositioning for one or more displays |
| WO2017210539A1 (en) | 2016-06-02 | 2017-12-07 | University Of Maryland, Baltimore | Compositions for inhibiting fibrin-vldl receptor-dependent inflammation and methods of treatment |
| WO2019011879A1 (en) | 2017-07-09 | 2019-01-17 | Rainer Henning | THERAPEUTIC AGENT FOR THE TREATMENT OF CAPILLARY LEAK SYNDROME |
| EP3912679A1 (en) | 2020-05-19 | 2021-11-24 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Bbeta-15-42 for the treatment of viral endothelitis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4766073A (en) * | 1985-02-25 | 1988-08-23 | Zymogenetics Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
| US4973577A (en) * | 1986-04-04 | 1990-11-27 | The Salk Institute For Biological Studies | FSH-releasing peptides |
| US5637677A (en) * | 1987-07-16 | 1997-06-10 | The Trustees Of The University Of Pennsylvania | Biologically active compounds and methods of constructing and using the same |
| US5965107A (en) | 1992-03-13 | 1999-10-12 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
| AU6522400A (en) * | 1999-08-10 | 2001-03-05 | Imarx Therapeutics, Inc. | Targeted thrombolytic agents |
| CN1518558B (zh) * | 2000-12-12 | 2010-06-16 | 菲布雷克斯医疗研究及开发有限责任公司 | 肽和/或蛋白质及其用于制备治疗性和/或预防性药物组合物的用途 |
| EP2154145B1 (en) * | 2003-01-15 | 2013-04-24 | International Institute of Cancer Immunology, Inc. | Dimerized peptide |
| PT1691827E (pt) | 2004-06-25 | 2009-11-23 | Fibrex Medical Res & Dev Gmbh | Utilização de péptidos derivados da cadeia b beta de fibrinogénio humano para o tratamento do choque |
-
2007
- 2007-02-23 DK DK07701339T patent/DK1987063T3/da active
- 2007-02-23 PT PT07701339T patent/PT1987063E/pt unknown
- 2007-02-23 DE DE602007002553T patent/DE602007002553D1/de active Active
- 2007-02-23 CA CA002641909A patent/CA2641909A1/en not_active Abandoned
- 2007-02-23 EP EP07701339A patent/EP1987063B1/en not_active Not-in-force
- 2007-02-23 ZA ZA200807027A patent/ZA200807027B/xx unknown
- 2007-02-23 ES ES07701339T patent/ES2333374T3/es active Active
- 2007-02-23 AT AT07701339T patent/ATE443722T1/de active
- 2007-02-23 PL PL07701339T patent/PL1987063T3/pl unknown
- 2007-02-23 SI SI200730112T patent/SI1987063T1/sl unknown
- 2007-02-23 AU AU2007219032A patent/AU2007219032B2/en not_active Ceased
- 2007-02-23 JP JP2008555561A patent/JP2009527503A/ja active Pending
- 2007-02-23 US US12/280,544 patent/US8067533B2/en not_active Expired - Fee Related
- 2007-02-23 WO PCT/AT2007/000096 patent/WO2007095661A1/en not_active Ceased
- 2007-02-23 US US11/678,538 patent/US20080004220A1/en not_active Abandoned
-
2009
- 2009-08-03 US US12/534,716 patent/US20100113740A1/en not_active Abandoned
- 2009-12-01 CY CY20091101266T patent/CY1109537T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20090018310A1 (en) | 2009-01-15 |
| ATE443722T1 (de) | 2009-10-15 |
| AU2007219032B2 (en) | 2011-06-09 |
| AU2007219032A1 (en) | 2007-08-30 |
| US20100113740A1 (en) | 2010-05-06 |
| US20080004220A1 (en) | 2008-01-03 |
| CY1109537T1 (el) | 2014-08-13 |
| ES2333374T3 (es) | 2010-02-19 |
| EP1987063B1 (en) | 2009-09-23 |
| PL1987063T3 (pl) | 2010-03-31 |
| US8067533B2 (en) | 2011-11-29 |
| JP2009527503A (ja) | 2009-07-30 |
| SI1987063T1 (sl) | 2010-02-26 |
| CA2641909A1 (en) | 2007-08-30 |
| PT1987063E (pt) | 2009-12-15 |
| DE602007002553D1 (de) | 2009-11-05 |
| WO2007095661A1 (en) | 2007-08-30 |
| WO2007095661A8 (en) | 2009-07-09 |
| ZA200807027B (en) | 2009-12-30 |
| EP1987063A1 (en) | 2008-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU23932B1 (es) | Sales farmacéuticamente aceptables de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo y sus usos en terapia | |
| MX384206B (es) | Formulaciones de inhibidores de dpp iv | |
| DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
| CL2007003685A1 (es) | Compuestos derivados de indol con un anillo unido en las posiciones 4 y 5; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion viral. | |
| CL2007000161A1 (es) | Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
| CL2007003684A1 (es) | Compuestos derivados de indol con un anillo unido en las posiciones 5 y 6; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion viral. | |
| CY1109537T1 (el) | Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης | |
| EA200802444A1 (ru) | Стабилизированные фармацевтические композиции, содержащие фезотеродин | |
| BRPI0509894A (pt) | composições farmacêuticas compreendendo um amido anfifìlico | |
| BR112017025108A2 (pt) | compostos seletivos de pyy e usos dos mesmos | |
| NO20074823L (no) | Rasagilin-formuleringer med forbedret innholdsensartethet | |
| NO20081038L (no) | Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering | |
| WO2008069917A3 (en) | Novel cyclic peptides | |
| BRPI1009392A2 (pt) | "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica." | |
| UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
| BRPI0717369A2 (pt) | Composto, medicamento, composição farmacêutica que o contém e uso do composto. | |
| EA201170512A1 (ru) | Композиция для перорального введения | |
| DE502007005902D1 (de) | -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate | |
| BRPI0820985A2 (pt) | Composto derivado de 5-aminociclometil-oxazondin-2-ona, medicamento e composição farmacêutica que os contém e uso dos mesmos | |
| BRPI0720684A2 (pt) | composto, medicamento, composição farmacêutica que contém e uso do composto | |
| DK2071917T3 (da) | Emballeringssystem til farmaceutiske sammensætninger og kit til intravenøs administration | |
| CL2007002315A1 (es) | Compuestos derivados de piridina;composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en enfermedades o trastornos que comprenden el dolor y/o sindrome del intestino irritable. | |
| NO20065898L (no) | 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner | |
| MA31227B1 (fr) | Composition pharmaceutique renfermant du phloroglucinol et du paracetamol. | |
| ATE460934T1 (de) | Pharmazeutische zubereitungen von ciprofloxacin |